Home

LifeMD, Inc. - Common Stock (LFMD)

8.6200
+2.5200 (41.31%)
NASDAQ · Last Trade: Apr 29th, 5:45 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close6.100
Open8.030
Bid8.380
Ask8.420
Day's Range7.020 - 8.690
52 Week Range3.990 - 12.88
Volume21,173,002
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume663,669

Chart

About LifeMD, Inc. - Common Stock (LFMD)

Lifemd Inc is a biotechnology company focused on advancing personalized medicine by leveraging cutting-edge technology and data analytics to develop innovative diagnostic solutions and therapeutics. Their mission centers around improving patient outcomes through tailored healthcare approaches, harnessing the power of genetic information and biomarkers to better understand individual health traits and disease predispositions. By aiming to provide precise treatment options, Lifemd Inc is dedicated to transforming the landscape of healthcare and empowering patients with actionable insights for managing their health. Read More

News & Press Releases

Tuesday's session: top gainers and loserschartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · April 29, 2025
Why Hims & Hers Health and LifeMD Are Skyrocketing Todayfool.com
Via The Motley Fool · April 29, 2025
Keep an eye on the top gainers and losers in Tuesday's session.chartmill.com
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · April 29, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · April 29, 2025
These stocks are gapping in today's sessionchartmill.com
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · April 29, 2025
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovybenzinga.com
LifeMD shares are trading higher Tuesday after the company announced it will offer access to Wegovy.
Via Benzinga · April 29, 2025
Top movers in Tuesday's pre-market sessionchartmill.com
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · April 29, 2025
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operatorsstocktwits.com
Patients will be able to access Novo Nordisk’s direct-to-patient online pharmacy, NovoCare, through the telehealth providers.
Via Stocktwits · April 29, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 29, 2025
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepboundinvestors.com
The deal allows Hims & Hers to sell Eli Lilly's Zepbound on its telehealth platform.
Via Investor's Business Daily · April 1, 2025
Tuesday's session: top gainers and loserschartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · March 11, 2025
Gapping stocks in Tuesday's sessionchartmill.com
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 11, 2025
What's going on in today's after hours sessionchartmill.com
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · March 10, 2025
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · March 11, 2025
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'benzinga.com
U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premarket trading.
Via Benzinga · March 11, 2025
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?benzinga.com
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.
Via Benzinga · March 10, 2025
Earnings Scheduled For March 10, 2025benzinga.com
Via Benzinga · March 10, 2025
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session.chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via Chartmill · February 21, 2025
Gapping stocks in Friday's sessionchartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · February 21, 2025
Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via MarketBeat · July 24, 2024
3 Overlooked Telehealth Stocks Poised for a Comebackinvestorplace.com
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement.
Via InvestorPlace · July 16, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · June 10, 2024
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · June 4, 2024
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments
Via MarketBeat · June 3, 2024
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result
Via MarketBeat · May 28, 2024